Mecamylamine increases cigarette smoking in psychiatric patients [4]

Journal of Clinical Psychopharmacology

Volumn 20, Issue 6, 2000, Pages 706-707

  Marx, Christine E ^a   McIntosh, Elizabeth ^b   Wilson, William H ^c   McEvoy, Joseph P ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d John Umstead Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; MECAMYLAMINE;

ADULT; CIGARETTE SMOKING; CONTROLLED STUDY; DEPENDENT PERSONALITY DISORDER; DOSE RESPONSE; DRUG EFFECT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MENTAL PATIENT; PRIORITY JOURNAL; SMOKING;

ADULT; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MECAMYLAMINE; MENTAL DISORDERS; MIDDLE AGED; NICOTINE; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SMOKING; TOBACCO USE DISORDER;

EID: 0033681162     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200012000-00023     Document Type: Letter

References (8)

1. 2, h α4β4, and h α7 expressed in Xenopus oocytes
2. Influencing cigarette smoking with nicotine antagonists
3. Effects of mecamylamine on human cigarette smoking and subjective ratings
4. Mecamylamine pre-treatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level
5. Mecamylamine increases nicotine preference and attenuates nicotine discrimination
6. Increased levels of the nicotine metabolite continine in schizophrenic smokers compared to other smokers
7. Nicotine intake in smokers increases following a single dose of haloperidol
8. Haloperidol increases smoking in patients with schizophrenia